Previous 10 | Next 10 |
Gainers: Inspira Technologies (NASDAQ:IINN) +103%, Ensysce Biosciences (NASDAQ:ENSC) +53%, Jasper Therapeutics (NASDAQ:JSPR) +24%, Ambrx Biopharma (NYSE:AMAM) +17%, iSpecimen (NASDAQ:ISPC) +15%. Losers: Reata Pharmaceuticals (NASDAQ:RETA)...
Sesen Bio (NASDAQ:SESN) announces its anticipated regulatory path forward for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) following its Clinical Type A meeting with the FDA, which occurred on December 8, 2021. Shares down 18% premarket a...
Company plans to conduct an additional clinical trial for potential resubmission of BLA Company expects to hold a Type C meeting with the FDA in early 2022 to discuss the clinical trial protocol Sesen Bio (Nasdaq:SESN), a late-stage clinical company developing target...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With its latest variant (Omicron) spreading, it seems Covid-19 will continue to play a major role in world events in 2022, just like it did in 2020, and in 2021. With this, pandemic-related drug stocks will likely remain ho...
3 Penny Stocks to Add to Your December 2021 Watchlist As we head further into December, investors continue to look for the best penny stocks to buy. To do so takes a thorough understanding of what’s going on in the stock market and how it may affect either penny stocks or blue ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In recent months, the market’s appetite for penny stocks has been seriously curbed. This makes sense, given that cryptocurrencies have again become the risky plays favored by most retail speculators. Success in inves...
Sesen Bio (Nasdaq: SESN ), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the strengthening of its medical team with the hiring of Dominika Kowalski as Senior Director of Global Drug Safety...
Reddit Penny Stocks To Watch as November Comes to an End With November almost over, plenty of penny stocks continue gaining momentum. Although it can be difficult to stumble upon the best penny stocks to buy , with a proper trading strategy, it can be much easier than previously ima...
Sesen received a CRL in August. Another trial will be needed. Sesen held a Type A meeting with the FDA on Oct. 29 on the CMC questions. For further details see: Sesen Bio: Interesting Price Drop After CRL
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Jane Pritchett Henderson, previously a member of Sesen Bio’s Board of Directors and the Chair of the Boardȁ...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...